Keyword
Quick search:
Result Content Outlet Published Research
Result Content Outlet Published Research
1 Nuplazid to Treat Alzheimer's Psychosis Likely Back Before FDA Alzheimer's News Today 12 days ago
2 Acadia slims Nuplazid label expansion bid in hopes of clinching Alzheimer's dementia nod without extra studies FiercePharma 28 days ago
3 Acadia puts blame on FDA as Nuplazid rejected for dementia - pharmaphorum 10 months ago
4 Data Support Long-term Efficacy of Nuplazid for Psychosis Parkinson's News Today 7 months ago
5 New Nuplazid use in limbo after US knockback Vantage 11 months ago
6 Nuplazid increases risk for death in older adults with Parkinson's disease Healio 5 months ago
7 #AANAM – Nuplazid Not Linked to Side Effects Common to Antipsychotics Alzheimer's News Today 9 months ago
8 Dementia and Light Activity; Controversial CTE Clinics; HHS Updates Alzheimer's Plan MedPage Today 21 days ago
9 ACADIA Pharmaceuticals : J.P. Morgan Presentation 2022 marketscreener.com 7 days ago
10 Zydus Cadila gets USFDA nod for Acadia’s Parkinson’s drug Ultra News 27 days ago
11 Pimavanserin Use Linked With Greater Risk of Hospitalization, Mortality in Patients With Parkinson Disease AJMC.com Managed Markets Network 5 months ago
12 Parkinson's drug may ease dementia-linked psychosis UPI News 6 months ago
13 Acadia Pharmaceuticals to Present Data on Pimavanserin in Patients with Parkinson's Disease Dementia with Psychosis from the HARMONY trial at the 14th Clinical Trials on Alzheimer's Disease (CTAD) Conference Business Wire 3 months ago
14 Long-term Nuplazid Safe, Well-tolerated by Parkinson's Psychosis... Parkinson's News Today 2 years ago
15 In $900M+ deal, rare disease biotechs team up on RNA therapies for CNS developmental disorders Endpoints News 4 days ago
16 Many Parkinson's Patients Who Start Antipsychotics Discontinue Therapy Parkinson's News Today 7 months ago
17 Nuplazid’s schizophrenia flop provides Advance warning Vantage 2 years ago
18 FDA Approves Nuplazid for Capsule Sprinkling Parkinson's News Today 1 year ago
19 Nuplazid Shows Sustained Easing of Parkinson's Psychosis, Trial Reports Parkinson's News Today 2 years ago
20 Acadia Submits Supplemental New Drug Application for Nuplazid Parkinson's News Today 2 years ago
21 Add-On Nuplazid Gets a Win in Early Schizophrenia Trial MedPage Today 1 year ago
22 Acadia Pharmaceuticals Reports Third Quarter 2021 Financial Results Business Wire 2 months ago
23 FDA to Review Nuplazid as Treatment for Dementia-related Psychosis Parkinson's News Today 1 year ago
24 ACADIA Pharmaceuticals shares are trading higher after the company announced plans for a resubmission of its supplemental New Drug Application to the FDA for NUPLAZID. Benzinga 29 days ago
25 Nuplazid (Pimavanserin) for Parkinson's Disease Parkinson's News Today 5 years ago
26 Acadia's Nuplazid Shows Mixed Results in Major Depression Study BioSpace 1 year ago
27 ACADIA Pharmaceuticals Announces U.S. FDA Accepted for Filing the Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis Business Wire 1 year ago
28 Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the Alzheimer's Association International Conference 2021 (AAIC) Business Wire 6 months ago
29 Acadia's Nuplazid Fails to Prove Effectiveness in Schizophrenia Trial BioSpace 2 years ago
30 Safety watchdog questions FDA's approval of Parkinson's psychosis drug CNN 3 years ago
31 A would-be epic — in 60 seconds: Acadia and Strikeforce go cinematic for Parkinson's treatment Medical Marketing and Media 2 months ago
32 Acadia gives voice to personal stories about Parkinson's psychosis in new bilingual campaign FiercePharma 2 months ago
33 Acadia's Nuplazid Hits the Mark in Late-Stage Dementia-Related Psychosis Trial BioSpace 2 years ago
34 Benefits of Acadia's Nuplazid Outweigh Risks for Parkinson's... Parkinson's News Today 3 years ago
35 FDA worried drug was risky; now reports of deaths spark concern CNN 4 years ago
36 ACADIA Pharmaceuticals Submits Supplemental New Drug Application to US FDA for NUPLAZID® (pimavanserin) for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis BioSpace 2 years ago
37 Once-a-day Capsule for Nuplazid and Lower Dose Option Approved for... Parkinson's News Today 4 years ago
38 FDA approves new formulation, dosage strength of Nuplazid for Parkinson's psychosis Healio 4 years ago
39 FDA concludes examination of Parkinson's drug CNN 3 years ago
40 New Parkinson's psychosis drug target of DOJ investigation CNN 3 years ago
41 HealthWell Opens Fund to Help Parkinson's Patients With Psychosis Parkinson's News Today 3 months ago
42 ACADIA Halts Psychosis Trial Early After Nuplazid Hits the Mark BioSpace 2 years ago
43 #AAN2018 Nuplazid's Safety, Efficacy in Treating Parkinson's Psychosis Seen in Real-life Studies 4 years ago
44 Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results Business Wire 11 months ago
45 Parkinson's Therapy Nuplazid (Pimavanserin) Reviewed as Treatment for Psychosis Parkinson's News Today 5 years ago
46 New drug for psychosis in Parkinson's raises hopes — and concerns STAT 6 years ago
47 Nuplazid Review Endorses Treatment, But Pinpoints Areas for More Study Parkinson's News Today 4 years ago
48 Experts: Nuplazid's Risks for Parkinson's Psychosis Don't Appear Too High Parkinson's News Today 4 years ago
49 FDA Continuing to Monitor Nuplazid Use, Agency Says in Response to... Parkinson's News Today 4 years ago
50 Acadia's Nuplazid misses the mark in major depressive disorder trial PMLiVE 1 year ago
51 Forbes Ranks Maker of Nuplazid 11th-Most Innovative Growth Company Parkinson's News Today 4 years ago
52 How I am fighting a fatal brain disease with vinyl records AL.com 2 days ago
53 Acadia Pharmaceuticals: Refunding A Former Champion Seeking Alpha 4 months ago
54 FDA Approves ACADIA Pharmaceuticals' NUPLAZID™ (pimavanserin) The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinson's Disease Psychosis 6 years ago
55 Parkinson's Psychosis Therapies Nuplazid and Clozaril Touted in Review Parkinson's News Today 4 years ago
56 Acadia debuts first Nuplazid branded ads, aiming to spark talk of Parkinson's psychosis FiercePharma 3 years ago
57 The rising cost of prescription drugs has many people skipping their medications ksltv.com 4 months ago
58 FDA approves first drug to treat hallucinations and delusions associated with Parkinson's disease | FDA FDA.gov 6 years ago
59 Study Weighs Nuplazid, Seroquel Mortality Risks in Parkinson's Psychosis Parkinson's News Today 3 years ago
60 Is The FDA Going To Do Anything About Acadia Pharmaceuticals' Nuplazid? Seeking Alpha 3 years ago
61 FDA's toughness toward AbbVie, FibroGen and Acadia raise worries of more stringent drug reviews: analyst FiercePharma 10 months ago
62 Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug PMLiVE 6 years ago
63 FDA Advisory Committee Concludes Nuplazid Beneficial for Parkinson's Disease Psychosis Treatment Parkinson's News Today 6 years ago
64 ACADIA Pharmaceuticals Announces Top-line Results from the Phase 3 CLARITY Study Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder Business Wire 1 year ago
65 A new drug reduces risk of psychosis relapse in patients with dementia Massive Science 2 months ago
66 FDA re-examines safety of controversial new drug CNN 4 years ago
67 Acadia declares early win on Nuplazid dementia study, stunning analysts and sending shares soaring Endpoints News 2 years ago
68 ACADIA Pharmaceuticals Files New Drug Application for NUPLAZID In... Parkinson's News Today 6 years ago
69 New Phase 3 Trial to Test Nuplazid for Parkinson's Psychosis in... Parkinson's News Today 4 years ago
70 Three Pharma Companies Seek to Address FDA Rejections BioSpace 2 months ago
71 Shuman Glenn & Stecker Investigates Acadia Pharmaceuticals, Inc. Business Wire 1 year ago
72 5 FDA approval decisions to watch in the second quarter BioPharma Dive 10 months ago
73 FDA approves Acadia Pharmaceuticals' Nuplazid Business Insider 6 years ago
74 Treating Parkinson's Psychosis with Oral Cannabidiol Focus of UK Phase 2 Study Parkinson's News Today 2 years ago
75 ACAD 8-DAY DEADLINE ALERT: Hagens Berman Encourages Acadia Pharmaceuticals (ACAD) Investors with Losses to Contact the Firm Yahoo Finance 7 months ago
76 'Erratic' FDA and inconsistent drug decisions put doctors off new meds: survey FiercePharma 6 months ago
77 Acadia: Surprise, Surprise Seeking Alpha 10 months ago
78 ACADIA Pharma files for US approval of Nuplazid for Parkinson's diseas The Pharma Letter 6 years ago
79 Acadia Pharma's psychosis drug proven better than placebo in dementia patients Reuters 2 years ago
80 Acadia wins FDA approval for first drug to treat Parkinson's disease psychosis BioPharma Dive 6 years ago
81 FDA Repays Industry by Rushing Risky Drugs to Market ProPublica 4 years ago
82 FDA Action Alert: Merck, Aveo and Acadia BioSpace 10 months ago
83 New ADHD Drug OK'd; Pimavanserin Rejected for Dementia Psychosis MedPage Today 10 months ago
84 Acadia Pharmaceutical's Nuplazid Pricing Is Good News for Shareholders TheStreet.com 6 years ago
85 Drug helped dementia patients curb their hallucinations and delusions Los Angeles Times 2 years ago
86 ACADIA Pharmaceuticals Initiates Phase 3 CLARITY Program with Pimavanserin as Adjunctive Treatment for Major Depressive Disorder BioSpace 3 years ago
87 BRIEF-Acadia Submits Supplemental NDA To U.S. FDA For Nuplazid For Treatment Of Delusions Associated With Dementia-Related Psychosis Reuters 2 years ago
88 The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Symptoms of Schizophrenia Yahoo Finance 2 months ago
89 U.S. FDA accepts Acadia's application for dementia drug Reuters 1 year ago
90 Is Drug Good for Some Alzheimer’s Patients? The Wall Street Journal 9 months ago
91 FDA release on drug for treating Parkinson's psychosis lacks some key details | HealthNewsReview.org 6 years ago
92 ACADIA Pharmaceuticals: Lower ADP Enrollment, Thoughts On Nuplazid Launch Seeking Alpha 5 years ago
93 Neurocrine, ACADIA: Fast Growing Health Care Stocks That Are Underperforming Forbes 3 months ago
94 Acadia Halts Work on Depression Drug After Late-Stage Trial Failure Xconomy 1 year ago
95 Global Schizophrenia Disease Analysis and Market Report 2020-2027: Uptake of LAIs will Flourish and Drug Developers will Reap the Rewards ResearchAndMarkets.com 8 months ago
96 FDA OKs Pimavanserin for Hallucinations in Parkinson's MedPage Today 5 years ago
97 Drug can curb dementia´s delusions, researchers find Daily Mail 2 years ago
98 Experimental Treatments for Alzheimer's Disease Alzheimer's News Today 8 months ago
99 ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Stephen Davis at 39th Annual JPMorgan Healthcare Conference (Transcript) Seeking Alpha 1 year ago
100 A Family Caregiver's Only Alternative With Alzheimer's Disease Alzheimer's News Today 5 months ago